Abstract
Executive function deficits are commonly observed in children diagnosed with attention deficit hyperactivity disorder (ADHD). This research investigates the effectiveness of neurofeedback training (NFT) in improving executive functions among this group. Studies were meticulously selected following stringent inclusion and exclusion criteria. The quality of these studies was assessed using the PEDro scale. Seventeen RCT studies were identified, totaling 939 participants. We observed significant improvements in global executive function (p < 0.055), inhibitory control (p < 0.0001) and working memory (p < 0.05) following NFT. Notably, NFT exceeding 1,260 min was more effective in enhancing inhibitory control (p < 0.01) and working memory (p < 0.01). Additionally, the effects of NFT on inhibitory control (p = 0.05) and working memory (p < 0.01) were found to be enduring. NFT is an effective intervention for improving inhibitory control and working memory in children with ADHD. Working memory exhibits a more significant enhancement when the duration exceeds 1260 min, while inhibitory control follows closely behind. Moreover, it has a more sustained effect on working memory, alongside a notable albeit secondary effect on inhibitory control.
Keywords: Neurofeedback training, Executive function, ADHD, Children, Meta-analysis
Subject terms: Human behaviour, Neurodevelopmental disorders, Diseases
Introduction
ADHD, which is one of the most common mental disorders in children, is defined by attention challenges, heightened activity levels, and impulsivity. It affects about 10% of children worldwide1,2. And approximately half of the children diagnosed with ADHD exhibit impaired executive function (EF), which is a significant characteristic of the condition as indicated by research findings3–5.
Executive function, a higher-order cognitive process, is integral to managing complex cognitive tasks and involves inhibitory control, working memory, and cognitive flexibility6. This capacity is pivotal for regulating diverse cognitive processes7. The developmental phase of executive function is crucial for children, influencing their academic performance8,9, emotion regulation10, and social functioning11. Furthermore, deficits in executive function correlate with a range of challenges including academic difficulties, behavioral problems, social struggles, and long-term psychological maladjustment12. This highlights the significance of implementing effective prevention and intervention strategies.
Pharmacological therapy, involving the use of amphetamines and methylphenidate, is a prevalent strategy for managing ADHD symptoms13,14. However, these treatments may induce side effects, including decreased appetite, sleep disturbances, nausea, and headaches. Additionally, prolonged use of pharmacological therapy could potentially result in stunted growth and cardiovascular risks15–17. Given these limitations, there is a critical need to explore non-invasive alternatives for effectively improving executive function in children with ADHD.
Neurological Techniques such as neurofeedback, transcranial stimulation, and hyperscanning are increasingly utilized in the treatment of children with neurodevelopmental disorders. Among these methods, neurofeedback has become the most widely adopted18. NFT is a noninvasive therapy designed to enhance brain function by monitoring and modifying brain electrical activity. In this process, participants receive instantaneous feedback on their brainwave patterns, enabling them to adjust and enhance specific brain regions based on this data19. By reviewing the existing researches, it was found that the number of studies on NFT and children has increased over time (Fig. 1A). The United Kingdom, Germany, the Netherlands, Iran, China, Switzerland, and Spain are pivotal contributors of NFT for children, making substantial advancements in this area (Fig. 1B). In particular, the number of research articles on neurofeedback training for children with ADHD ranked second (Fig. 1C). Children with ADHD often struggle with self-control. The goal of NFT is to enhance the brain’s self-regulation in order to ameliorate and optimize individuals’ cognition. Consequently, the current study aims to conduct an exhaustive review of the existing literature on the interplay between NFT and executive function in children with ADHD, hoping to provide valuable insights for future research.
Fig. 1.
Literature review.
Methods
This study strictly followed the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) framework for literature screening20. The protocol for the systematic review was registered with PROSPERO (CRD42024540735).
Search strategy
The literature review was performed across three databases: PubMed, EBSCO, and Web of Science. The search was restricted to English-language articles published from January 2000 to January 2024. To refine the search efficacy, a tactical mix of topic-specific and broad terms was utilized. Detailed below are the search terms employed: “neurofeedback” OR “brainwave biofeedback” OR “alpha feedback” OR “EEG Feedback” OR “electromyography feedback” OR “neurotherapy” OR “slow cortical potential” OR “SCP” OR “sensory motor rhythm” OR “SMR” AND “ADHD” OR “Attention Deficit Disorders with Hyperactivity” OR “Hyperkinetic Syndrome” AND “child” OR “children” OR “childhood” OR “pediatric” AND “cognition” OR “cognitive function” OR “cognitive ability” OR “cognitive performance” OR “executive function” OR “inhibition” OR “inhibitory control” OR “cognitive control” OR “working memory” OR “cognitive flexibility.”
Inclusion criteria
(1) Participants: The study population comprised children and adolescents aged 6 to 18 years diagnosed with ADHD according to the criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM) or the International Classification of Diseases (ICD). (2) Study Design: Included in the analysis were studies employing randomized or non-randomized controlled trials, as well as quasi-experimental designs. These studies were required to provide detailed statistical data including participant counts, means, standard deviations, and other pertinent information. (3) Types of Intervention: Types of Intervention: Neurofeedback has been implemented as one of the treatment interventions. Studies have compared NF to a control group or other interventions. (4) Variable: The primary independent variable under investigation is NFT. The dependent variables encompass cognitive functions, notably inhibitory control, working memory, and cognitive flexibility. (5) Outcome Measures: The included studies must utilize validated tools to assess executive function, such as neurocognitive tasks or questionnaires.
Exclusion criteria
(1) Participants: The studies included mixed population samples of adults and children. (2) Study Design: Non-intervention studies, qualitative research, case studies, observational studies, review articles, conference abstracts, books, and other non-empirical literature forms were excluded. (3) Types of Intervention: The studies lack a control group or other comparative interventions.
Study selection and data extraction
Upon completing the literature search, the articles obtained were imported into NoteExpress for deduplication. Two researchers independently performed a preliminary screening of the articles based on their titles, abstracts, and keywords. Articles that passed this initial phase were then subjected to a more comprehensive review, which included a full-text examination. In instances of disagreement, a third researcher was consulted to achieve consensus on whether to include an article.
During the review process, both researchers systematically extracted essential information from each article, detailing the authors, country of publication, year of publication, and specifics regarding the study participants, such as number and age. Additionally, exhaustive details concerning the interventions (time, frequency, and duration), measurement tools employed, and the outcomes measured were meticulously recorded to ensure accuracy.
Quality assessment
The Physiotherapy Evidence Database (PEDro) scale is a validated and efficient instrument for assessing the methodological quality of research studies21. This scale includes 11 items that evaluate various aspects such as eligibility criteria, random allocation, concealment of allocation, baseline comparability, blinding of participants, therapists, and assessors, an attrition rate of ≤ 15%, implementation of intention-to-treat analysis, statistical comparisons between groups, and variability measurements. Each of items 2–11 is scored on a binary scale, where 1 point is given for criteria fulfillment and 0 points are assigned for non-fulfillment or ambiguous criteria. The total PEDro scale score is derived by summing these item scores, with interpretations as follows: scores below 4 denote poor quality, scores between 4 and 8 indicate good quality, and scores between 9 and 10 suggest high quality. The methodological quality of the included studies was independently assessed by two researchers using the PEDro criteria, with a third researcher consulted to resolve any disagreements.
Statistical analysis
Statistical analysis was performed using Review Manager 5.4 and Stata 12.0 software. For the meta-analysis, sample sizes, means, and standard deviations of both intervention and control groups were extracted pre- and post-intervention to compute the effect size. Considering the diversity in intervention durations and cognitive assessment methodologies, the SMD with a 95% CI was utilized as the aggregate effect size measure. The effect size was categorized as small (0.2–0.49), moderate (0.50–0.79), and large (≥ 0.8)22. Heterogeneity among the included studies was assessed using the Q-value and I2 statistic. The Q-value, reflecting total variation, denotes significant heterogeneity if p < 0.05 and no significant heterogeneity if p > 0.05. I2 quantifies the proportion of inter-study variance relative to total variance, with thresholds of 25%, 50%, and 75% indicating low, moderate, and high heterogeneity, respectively. A random effects model was applied in cases where p < 0.05 and I2 > 50%. In other scenarios, a fixed effects model was utilized23. And Egger’s methods are applied to indicate significant publication bias for the analysis exploring association between risk of NFT and executive function.
Results
Search results
Initial searches identified 503 relevant articles. Following deduplication and the exclusion of irrelevant literature, 394 articles remained. Preliminary evaluation based on titles and abstracts further refined the pool to 101 articles. A detailed examination of the full texts ultimately led to the inclusion of 17 articles for analysis. The article selection process is depicted in Fig. 2.
Fig. 2.
PRISMA flowchart diagram of the selection process of studies.
Study selection and characteristics
The studies incorporated in this review included 17 randomized controlled trials involving a total of 939 participants aged 6 to 17 years, all diagnosed with ADHD. Of these, 477 participants (approximately 50.8%) underwent EEG or fMRI NFT, while 462 participants (approximately 49.2%) were assigned to control groups. The duration of NFT sessions varied, ranging from 2 to 25 weeks, with a frequency of one to seven sessions per week. Each session lasted from 8.5 to 60 min, resulting in a total NFT duration of 119 to 2400 min. Table 1 presents detailed information regarding the characteristics of the participants, frequency and duration of NFT, and the measurements from the included studies.
Table 1.
Characteristics of the included studies.
| Study | Region | Age (year) | Sample | Design | Intervention | Intervention time | ASD diagnostic criteria | Measure index | Measure task |
|---|---|---|---|---|---|---|---|---|---|
| Alegria24 et al. (2017) | UK | 12–17 |
EG: n = 18 ICG: n = 13 |
RCT | Real-time fMRI NFT (rIFG) VS. No intervention |
2 weeks, 7 sessions/week, 8.5 min/session, total 119 min |
DSM-5, K-SADS-PL |
IC | GNG |
| Bakhsha-yesh25 et al. (2011) | Italy | 6–14 |
EG: n = 14 ACG: n = 14 |
RCT | EEG NFT (TBR) VS. EMG BF |
10–15 weeks, 2/3 sessions/week, 30 min/session, total 900 min |
ICD-10 | IC | CPT |
| Beauregard26 et al. (2006) | Canada | 8–12 |
EG: n = 15 ICG: n = 5 |
RCT | EEG NFT (TBR) VS. No intervention |
13.5 weeks, 3 sessions/week, 60 min/session, total 2400 min |
DSM-5 | IC | GNG |
| Bink27 et al. (2014) | Netherlands | 16 |
EG: n = 45 ACG: n = 26 |
RCT | EEG NFT (TBR) + TAU; VS. TAU |
25 weeks, 2–3 sessions/week, 40 min/session, total 1200 min |
DSM-5 |
WM; CF |
DSB; TL |
| Dobrakowski28 et al. (2020) | Poland | 6–12 |
EG: n = 24 ICG: n = 24 |
RCT | EEG NFT (PAF) VS. No intervention |
10 weeks, 1 session/week, 45 min/session, total 450 min |
DSM-5, ICD-10 | WM | N-back |
| Geladé29 et al. (2017) | Netherlands | 7–13 |
EG: n = 36 ACG: n = 37 |
RCT | EEG NFT (TBR) VS. PA |
10–12 weeks, 3 sessions/week, 45 min/session, total 1350 min |
DSM-5 |
IC, WM |
SST, VSWM |
| Geladé30 et al. (2018) | Netherlands | 7–13 |
EG: n = 33 ACG: n = 31 |
RCT | EEG NFT (TBR) VS. PA |
10–12 weeks, 3 sessions/week, 45 min/session, total 1350 min |
DSM-5 |
IC, WM |
SST, VSWM |
| Ging-Jehli31 et al. (2023) | USA | 7–10 |
EG: n = 55 ICG: n = 78 |
RCT | EEG NFT (TBR) VS. No intervention | not explicitly stated | DSM-5; AODS-2 | IC | IVA2-CPT, GNG |
| Heinrich32 et al. (2014) | Germany | 7–14 |
EG: n = 13 ICG: n = 9 |
RCT |
EEG NFT (SCP) VS. No intervention |
7 weeks, 7 sessions/week, 50 min/session, total 1250 min |
DSM-5; Diagnostic Checklist for ADHD |
IC | CPT |
| Maurizio33 et al. (2014) | Switzerland | 8.5–13 |
EG: n = 12 ACG: n = 2 |
RCT | EEG NFT (SCP + TBR) VS. No EMG BF |
12 weeks, 2–3 sessions/week, 30 min/session, total 1080 min |
DSM-5 | Global EF | BRIEF |
| Moradi34 et al. (2022) | Iran | 10.1 |
EG: n = 16 ICG: n = 16 |
RCT |
EEG NFT (TBR) VS. No Intervention |
3 months, 3 sessions/week, 15 min/session, total 1620 min |
DSM-5 |
IC, WM |
CPT, WWMT |
| Moreno-García35 et al. (2019) | Spain | 7–14 |
EG: n = 19 ACG1:n = 19 ACG2:n = 19 |
RCT |
EEG NFT (TBR) VS BT or PH |
20 weeks, 4 sessions/week, 24 min/session, total 40 session total 960 min |
DSM-5; ADHD RS-IV | IC | CPT |
| Shereena36 et al. (2019) | India | 6–12 |
EG: n = 15 ICG: n = 15 |
RCT |
EEG NFT (TBR) VS. No intervention |
3.5–5 months, 3–4 sessions/week, 20–40 min/session, total 1200 min |
ICD-10 |
IC, WM, CF |
GNG, N-back, CTT |
| Steiner37 et al. (2014) | Boston | 7–11 |
EG: n = 34 ACG: n = 34 ICG: n = 36 |
RCT | EEG NFT (TBR) VS. CT/No intervention |
5 months, 3 sessions/week, 45 min/session, total 1800 min |
DSM-5 | Global EF | BRIEF |
| Steiner38 et al. (2011) | Boston | 12.4 |
EG: n = 9 ICG: n = 13 |
RCT | EEG NFT (TBR) VS. No intervention |
4 months, 2 sessions/week, 45 min/session, total 1440 min |
DSM-5 | Global EF | BRIEF |
| Vollebregt39 et al. (2014) | Netherlands | 8–15 |
EG: n = 60 ICG: n = 60 |
RCT | EEG NFT (individualized: SMR, beta, theta) VS. No intervention |
15 weeks, 2 sessions/week, 20 min/session, total 720 min |
DSM-5 | WM | Digit span WISC-III |
| Wangler40 et al. (2011) | Germany | 8–12 |
EG: n = 59 ACG: n = 35 |
RCT | EEG NFT (SCP + TBR) VS. Attention Training |
9 weeks, 2–3 sessions/week, 50 min/session, total 1800 min |
DSM-5 | IC | ANT |
EG: Experimental Group; ICG: inactive controls group; RCT: Randomized Controlled Trial; rIFG: right inferior prefrontal cortex; ST: standard treatment; DSM-5: Diagnostic and Statistical Manual of Mental Disorders, 5th edition; K-SADS-PL: Kiddie Schedule of Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version; IC: Inhibitory Control; GNG: Go/No-go; ACG: active control group; EMG BF: Electromyogram Biofeedback; ICD-10: International Classification of Diseases, Tenth Revision; CPT: Continuous Performance Task; TAU: Treatment As Usual; WM: Working Memory; CF: Cognitive Flexibility; DSB: Digit Span Backward; TL: Tower of London; PAF: peak alpha frequency; PA: Physical Activity; SST: Stop-signal Task; VSWM: Visual Spatial Working Memory Task; AODS-2: Autism Diagnostic Observation Schedule, Second Edition; IVA2-CPT: Integrated Visual and Auditory Continuous Performance Test; EF: Executive Function; BRIEF: Behavior Rating Inventory of Executive Function; WWMT: Wechsler Working Memory Test; BT: Behavior Therapy; PH: Pharmacology; ADHD RS-IV: ADHD Rating Scale–IV; CTT: Color Trails Test; CT: cognitive training; WISC-III: Wechsler Intelligence Scale for Children, Three Edition; SMR: sensory motor rhythm; ANT: Attention Network Test.
Risk of bias assessment
The PEDro scale scores for the included studies ranged from 6 to 10, with an average score of 7.76. Notably, no study scored below 5. Specifically, eleven studies fell within the 6 to 8 range, and six studies achieved scores between 9 and 10. All studies fulfilled the criteria for eligibility, random allocation, an attrition rate of ≤ 15%, intention-to-treat analysis, statistical comparison between groups, and reporting of point measures and variability. Sixteen studies reported baseline comparability, twelve incorporated allocation concealment, ten implemented blinding of participants, six involved blinding of therapists, and five applied blinding of assessors. These assessments indicate that the overall quality of the literature is generally high, as detailed in Table 2. The risk of bias assessments for the included studies were displayed in Figs. 3 and 4.
Table 2.
Methodological quality of the included studies.
| Study | EC | RA | CA | CB | BP | BT | BA | AT ≤ 15% | IITA | SCBG | MV | Total score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alegria24 et al. (2017) | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 8 |
| Bakhshayesh25 et al. (2011) | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 7 |
| Beauregard26 et al. (2006) | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7 |
| Bink27 et al. (2014) | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7 |
| Dobrakowski28 et al. (2020) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Geladé29 et al. (2017) | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 9 |
| Geladé30 et al. (2018) | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 8 |
| Ging-Jehli31 et al. (2023) | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 |
| Heinrich32 et al. (2004) | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 8 |
| Maurizio33 et al. (2014) | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 |
| Moradi34 et al. (2022) | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 9 |
| Moreno-García35 et al. (2019) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Shereena36 et al. (2019) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Steiner37 et al. (2014) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 10 |
| Steiner38 et al. (2011) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Vollebregt39 et al. (2014) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 10 |
| Wangler40 et al. (2011) | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7 |
EC: Eligibility criteria; RA: Random allocation; CA: concealment of allocation; CB: comparability at baseline; BP: blinding of participants; BT: blinding of therapists; BA: blinding of assessors; AT ≤ 15%: attrition rate ≤ 15%; IITA: implementation of intention-to-treat analysis; SCBG: statistical comparison between groups; MV: measures of variability.
Fig. 3.
Risk of bias graph of all included study.
Fig. 4.
Risk of bias summary of all included study.
Meta-analysis results
Effect of NFT on EF
In the analysis of the relationship between NFT and global executive function, three studies incorporating 1116 participants were evaluated. These studies displayed low statistical heterogeneity (I2 = 0%, p > 0.05), which justified the use of a fixed effects model. The findings revealed a significant positive impact of NFT on inhibitory control (SMD = −0.44, 95% CI = −0.81 to −0.07, Z = 2.30, p < 0.05) (Fig. 5A).In the analysis of the relationship between NFT and inhibitory control, twelve studies incorporating 640 participants were evaluated. These studies displayed low statistical heterogeneity (I2 = 26%, p > 0.05), which justified the use of a fixed effects model. The findings revealed a significant positive impact of NFT on inhibitory control (SMD = 0.36, 95% CI = 0.18–0.53, Z = 4.04, p < 0.0001) (Fig. 5B). In terms of working memory, seven studies involving 370 participants were examined. The results showed a beneficial effect of NFT on working memory (SMD = 0.37, 95% CI = 0.01–0.74, Z = 2.01, p < 0.05), with high heterogeneity observed (I2 = 65%, p < 0.01) (Fig. 5C).
Fig. 5.
Pairwise meta-analysis. NFT effects on global executive function (A), inhibitory control (B), and working memory (C) by comparison group type (experimental group vs. control group). SD = Standard Deviation; Std Mean Difference = Standardized Mean Difference; Random = Random Effects Model; Fix = Fix Effects Model; IV = Inverse Variance (a method of weight allocation); CI = Confidence Interval; I2 = Higgins’ I2; ◆ = Overall effect estimates from all studies pooled together in this meta-analysis. If ◆ cross the line signifies no difference between groups (the same below).
Egger’s regression test indicated no publication bias in studies related to global executive function, inhibitory control and working memory ( all p > 0.05).
The dose–response effect of NFT on EF
This study utilized a subgroup comparison approach to evaluate the impact of different NFT durations on executive function among children diagnosed with ADHD. The duration of NFT sessions varied from 119 to 2400 min. Participants were divided into two groups based on the median duration of intervention: those receiving less than 1260 min of training were categorized as the short-term training group, while those with training durations exceeding 1260 min were classified as the long-term training group.
In the short-term training group, six studies involving 227 participants examined inhibitory control but found no significant difference between the neurofeedback and control groups (SMD = 0.221, 95% CI = −0.06–0.48, Z = 1.53, p > 0.05), with a low heterogeneity (I2 = 41%, p > 0.05) (Fig. 6A). Additionally, four studies with 190 participants focusing on working memory also reported no significant difference between the two groups (SMD = 0.31, 95% CI = −0.33–0.95, Z = 0.96, p > 0.05), while exhibiting high heterogeneity (I2 = 78%, p < 0.05) (Fig. 6B). Egger’s regression test indicated no publication bias in the studies on inhibitory control(p > 0.05) and working memory (p > 0.05) in the short-term neurofeedback group.
Fig. 6.
Pairwise meta-analysis. Short-term NFT effects on inhibitory control (A) and working memory (B) by comparison group type (experimental group vs. control group).
In the long-term training group, five studies with 280 participants focusing on inhibitory control revealed a significant difference between the NFT and control groups (SMD = 0.30, 95% CI = 0.10–0.58, Z = 2.75, p < 0.01), with low heterogeneity (I2 = 47%, p > 0.05) (Fig. 7A). Three studies with 180 participants focusing on working memory demonstrated a significant difference between the two groups (SMD = 0.441, 95% CI = 0.12–0.71, Z = 2.72, p < 0.01), also with low heterogeneity (I2 = 26%, p > 0.05) (Fig. 7B). The findings revealed that NFT had a significant positive impact on inhibitory control and working memory when participants underwent NFT for more than 1260 min. Egger’s regression test applied to the long-term neurofeedback group revealed a publication bias was detected in the studies on inhibitory control (p = 0.012 < 0.05) and working memory (p = 0.027 < 0.05).
Fig. 7.
Pairwise meta-analysis. Long-term NFT effects on inhibitory control (A) and working memory (B) by comparison group type (experimental group vs. control group).
The sustained effects of NFT on EF (6 to 12 months)
This study assessed the long-term effects of NFT on executive function, particularly focusing on the sustained impacts observable 6 to 12 months after the training. In the realm of inhibitory control, two studies highlighted a marginally significant difference between the NFT and control groups (SMD = 0.35, 95% CI = 0.00–0.69, Z = 1.96, p = 0.05), with no heterogeneity detected (I2 = 0%, p > 0.05) (Fig. 8A). Regarding working memory, three studies demonstrated a significant difference between the two groups (SMD = 0.63, 95% CI = 0.19–1.07, Z = 2.79, p < 0.01), though with high heterogeneity (I2 = 53%, p > 0.05) (Fig. 8B). Given the limited number of studies (only two) focusing on inhibitory control, publication bias testing was not conducted for this specific subset. However, Egger’s regression test applied to the studies on working memory revealed no evidence of publication bias ( p > 0.05).
Fig. 8.
Pairwise meta-analysis. sustained effects of NFT on inhibitory control (A) and working memory (B) by comparison group type (experimental group vs. control group).
Discussion
This study primarily focused on analyzing inhibitory control and working memory due to the limited research available on the relationship between NFT and cognitive flexibility. The findings of the meta-analysis indicated that NFT exerted a medium effect on both inhibitory control and working memory in children with ADHD. These results are consistent with those reported in several other meta-analyses41–43.However, these findings are subject to debate. A particular meta-analysis reported no significant improvement in executive function in children with ADHD following neurofeedback44. This outcome was associated with several contributing factors identified in the study. Firstly, the inclusion of only six studies raises concerns regarding potential bias and the limited sample size, underscoring the scarcity of randomized controlled trials (RCTs) in this area. Secondly, variations in the design of interventions, including the frequency and duration of the interventions, could have influenced the aggregated results45. Therefore, more comprehensive research is needed to fully explore the effects of NFT on inhibitory control and working memory, as well as to control for non-specific effects.
The results of the meta-analysis on neurofeedback and working memory in children with ADHD revealed considerable heterogeneity across studies, which is closely associated with variations in neurofeedback protocols. This analysis included three NFT protocols: TBR (5 studies), PAF(1 study), and personalized (1 study). The studies included predominantly used TBR neurofeedback training, which may be the most effective protocol. However, this conclusion needs to be validated by future research. In addition, the heterogeneity between neurofeedback and working memory studies may be related to the cognitive task paradigms. There are five cognitive task paradigms: DSB (1 study), N-back (2 studies), VSWM (2 studies), WMMT (2 studies), and DS-WISC-III (1 study). Given the potential influence of different neurofeedback protocols and cognitive task paradigms on the results, caution is warranted when interpreting the effects of NFT on working memory in children with ADHD. Due to the significant disparity in the number of studies across the various protocols and cognitive task paradigams, a detailed subgroup analysis was not conducted. Future meta-analyses should adopt stricter inclusion criteria and perform subgroup analyses to more clearly elucidate the specific effects of different neurofeedback protocols on working memory in children with ADHD.
The effectiveness of NFT in enhancing inhibitory control and working memory appears to be contingent on the duration of the training. Presently, there is no established consensus regarding the optimal duration for such training. The current study was divided into short-term NFT group and long-term NFT group according to the median intervention time. We found that short-term NFT training lasting less than 1260 min did not show a notable impact on inhibitory control and working memory. High heterogeneity is noted in short-term NFT on working memory. This heterogeneity may be attributed to variations in NFT protocols, including different frequencies and durations; and individual differences among ADHD children, such as age, symptom severity, and comorbidities. Additionally, the diversity in paradigms employed for cognitive task assessments may have contributed to this bias46. Given the complexity of cognitive structures, different cognitive paradigms may lead to variability in research outcomes. Therefore, future studies should aim to use a variety of cognitive measurement tools to comprehensively assess a broad range of cognitive components, in order to reduce the confounding effects of task-specific influences on the results.
While NFT training time exceeding this threshold (1260 min) demonstrates a small to moderate effect. However, it should be acknowledged that there is a publication bias in favor of the results of successful long-term neurofeedback training, potentially attributed to the limited number of studies included. Future studies should aim to increase sample sizes to enhance statistical power, refine experimental designs to minimize potential biases, and implement more rigorous control measures to better account for confounding variables. By carefully addressing these factors, future studies can strengthen the robustness and reliability of their conclusions, ultimately contributing to a clearer understanding of the effectiveness of NFT for ADHD.
This study further indicates that NFT has a medium to large, sustained effect on inhibitory control and working memory. Notably, the enhancement in executive functioning is sustained for at least 6–12 months post-training. This result is similar to the effect of NFT on attention and impulsivity in children with ADHD. Compared to no NFT control treatments, NFT appears to have more durable treatment effects on attentional and impulsivity reduction, for at least 6 months following treatment47. In addition, this study also found the enduring impact on working memory is more marked than on inhibitory control. This disparity may be related to the specific challenges faced by children with ADHD, who often struggle with control abilities. While NFT improves inhibitory control, achieving significant progress necessitates a long-term commitment48. Consequently, emphasizing the importance of focusing on inhibitory control in the daily management of ADHD in children is essential.
NFT incorporates a variety of protocols, each underpinned by distinct neurophysiological mechanisms, to improve executive function. A prevalent method for addressing ADHD is Theta-beta ratio (TBR) NFT, based on the Quantitative Electroencephalography (QEEG) protocol. In TBR neurofeedback, the upregulation of theta frequencies has been specifically linked to an increase in P3 amplitude in No-go tasks49. Protocols that involve training in beta upregulation or a combination of both theta and beta frequencies resulted in less specific effects. On the other hand, focusing exclusively on enhancing beta frequencies during NFT, without concurrent theta frequency regulation, consistently improved both response inhibition and conflict control50. Another method, slow cortical potentials (SCP) NFT, employs the Event-Related Potentials (ERP) protocol. Research indicates that SCP training, following neurofeedback sessions, contributes to an increase in the contingent negative variation (CNV), a change specifically attributed to this type of training40. SCP neurofeedback is designed to enhance negative cortical potentials in the somatosensory motor cortex, which improves attention resource allocation and ultimately enhances cortical regulatory functions in individuals with ADHD. A critical aspect of NFT is its ability to enhance brain neuroplasticity—the capacity of the brain to adapt and reorganize. This enhancement significantly contributes to improvements in executive functions. Future research should focus on optimizing and personalizing NFT protocols based on individual neurophysiological profiles to maximize enhancements in executive functions.
NFT is increasingly acknowledged as a non-pharmacological adjunctive approach to augment executive function in children diagnosed with ADHD. It is crucial to recognize neurofeedback as a complementary therapy rather than a standalone treatment. Its effectiveness can be considerably enhanced when integrated with other therapeutic strategies, such as cognitive therapy51 and cognitive-behavioral therapy (CBT). Research indicates that combining NFT with cognitive therapy yields more comprehensive improvements in executive functions. Specifically, cognitive training effectively enhances inhibitory control, whereas NFT demonstrates significant improvements in working memory52. The amalgamation of NFT with CBT has been extensively validated in numerous studies as significantly beneficial for improving the executive function of children with ADHD53–55. Additionally, integrating pharmacotherapy with NFT can be an effective complementary treatment strategy. Although NFT alone has shown a superior effect on executive function compared to medication56, the combination of both NFT and medication has proven more effective in reducing ADHD symptoms and enhancing executive functioning57.
In light of these findings, it is imperative for clinicians and researchers to embrace a diversified and pragmatic treatment approach for children with ADHD. This strategy should ideally integrate NFT, medication therapy, and cognitive behavioral therap58. This comprehensive treatment model is designed to achieve superior therapeutic outcomes and is actively endorsed at an international level59.
Conclusion
NFT is an effective intervention for improving executive function in children with ADHD, specifically inhibitory control and working memory. This approach demonstrates a more pronounced impact on working memory when extended beyond 1000 min, with inhibitory control following closely behind. Furthermore, the evidence suggests that NFT may have sustained effects on both working memory and inhibitory control. Given the relatively small number of studies assessing long-term effects and the potential for publication bias, further research is necessary to confirm these effects and to better understand the mechanisms underlying NFT’s impact on executive functions in children with ADHD.
Supplementary Information
Author contributions
Xiaoke Zhong, Xiaoxia Yuan, and Changhao Jiang wrote the main manuscript text. Xiaoke Zhong and Yuanfu Dai prepared figures. All authors reviewed the manuscript.
Funding
This work was supported by Beijing Key Project of Philosophy and Social Sciences (No. 19YTA001) and Emerging Interdisciplinary Platform for Medicine and Engineering in Sports (20230929).
Data availability
The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.
Declarations
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-025-94242-4.
References
- 1.Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J. & Rohde, L. A. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am. J. Psychiatry164, 942–948 (2007). [DOI] [PubMed] [Google Scholar]
- 2.Wang, Y. et al. Connections between the middle frontal gyrus and dorso-ventral attention network associate with the development of attentional symptoms. Biol. PsychiatryS0006–3223, 01291–01295 (2024). [DOI] [PubMed] [Google Scholar]
- 3.Westby, C. & Watson, S. Perspectives on attention deficit hyperactivity disorder: Executive functions, working memory, and language disabilities. Semin. Speech. Lang.25, 241–254 (2004). [DOI] [PubMed] [Google Scholar]
- 4.Lambek, R. et al. Executive dysfunction in school-age children with ADHD. J. Atten. Disord.15, 646–655 (2011). [DOI] [PubMed] [Google Scholar]
- 5.Rubia, K. Cognitive neuroscience of attention deficit hyperactivity disorder (ADHD) and its clinical translation. Front. Hum. Neurosci.12, 100 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Diamond, A. Executive functions. Annu. Rev. Psychol.64, 135–168 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wilks, T., Gerber, R. J. & Erdie-Lalena, C. Developmental milestones: Cognitive development. Pediatr. Rev.31, 364–367 (2010). [DOI] [PubMed] [Google Scholar]
- 8.Biederman, J. et al. Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J. Consult. Clin. Psychol.72(5), 757–766 (2004). [DOI] [PubMed] [Google Scholar]
- 9.Shroff, D. M. et al. Predictors of executive function trajectories in adolescents with and without ADHD: Links with academic outcomes. Dev. Psychopathol.12, 1–14 (2023). [DOI] [PubMed] [Google Scholar]
- 10.Groves, N. B. et al. Executive functioning and emotion regulation in children with and without ADHD. Res. Child. Adolesc. Psychopathol.50, 721–735 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Ben-Asher, E., Porter, B. M., Roe, M. A., Mitchell, M. E. & Church, J. A. Bidirectional longitudinal relations between executive function and social function across adolescence. Dev. Psychol.59(9), 1587–1594 (2023). [DOI] [PubMed] [Google Scholar]
- 12.Diamond, A. Why improving and assessing executive functions early in life is critical. In Executive Function in Preschool-Age Children: Integrating Measurement, Neurodevelopment, and Translational Research Vol. 1 (eds Griffin, J. A. et al.) 11–43 (American Psychological Association, 2016). [Google Scholar]
- 13.Childress, A. C., Komolova, M. & Sallee, F. R. An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations. Expert. Opin. Drug. Met. Toxicol.15, 937–974 (2019). [DOI] [PubMed] [Google Scholar]
- 14.Shellenberg, T. P., Stoops, W. W., Lile, J. A. & Rush, C. R. An update on the clinical pharmacology of methylphenidate: Therapeutic efficacy, abuse potential and future considerations. Expert. Rev. Clin. Pharmacol.13, 825–833 (2020). [DOI] [PubMed] [Google Scholar]
- 15.Schelleman, H. et al. Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics.127, 1102–1110 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Swanson, J. M. et al. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: Symptom persistence, source discrepancy, and height suppression. J. Child. Psychol. Psychiatry58(6), 663–678 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Biederman, J. et al. Evidence of low adherence to stimulant medication among children and youths with ADHD: An electronic health records study. Psychiatr. Serv.70, 874–880 (2019). [DOI] [PubMed] [Google Scholar]
- 18.Hidalgo-Muñoz, A. R., Acle-Vicente, D., García-Pérez, A. & Tabernero-Urbieta, C. Application of neurotechnology in students with ADHD: An umbrella review. Comunicar.31, 59–70 (2023). [Google Scholar]
- 19.Goode, A. P. et al. Nonpharmacologic treatments for attention-deficit/hyperactivity disorder: A systematic review. Pediatrics.141(6), e20180094 (2018). [DOI] [PubMed] [Google Scholar]
- 20.Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS. Med.6, e1000097 (2009). [PMC free article] [PubMed] [Google Scholar]
- 21.Herbert, R., Moseley, A. & Sherrington, C. PEDro: A database of randomised controlled trials in physiotherapy. Health. Inf. Manag.28, 186–188 (1998). [DOI] [PubMed] [Google Scholar]
- 22.Hedges, L. V., & Olkin, I. Statistical methods for meta-analysis (Orlando 1985).
- 23.Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med.21, 1539–1558 (2002). [DOI] [PubMed] [Google Scholar]
- 24.Alegria, A. A. et al. Real-time fMRI neurofeedback in adolescents with attention deficit hyperactivity disorder. Hum. Brain. Mapp.38, 3190–3209 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Bakhshayesh, A. R., Hänsch, S., Wyschkon, A., Rezai, M. J. & Esser, G. Neurofeedback in ADHD: A single-blind randomized controlled trial. Eur. Child. Adolesc. Psychiatry20, 481–491 (2011). [DOI] [PubMed] [Google Scholar]
- 26.Beauregard, M. & Lévesque, J. Functional magnetic resonance imaging investigation of the effects of neurofeedback training on the neural bases of selective attention and response inhibition in children with attention-deficit/hyperactivity disorder. Appl. Psychophysiol. Biofeedback.31(1), 3–20 (2016). [DOI] [PubMed] [Google Scholar]
- 27.Bink, M., van Nieuwenhuizen, C., Popma, A., Bongers, I. L. & van Boxtel, G. J. Neurocognitive effects of neurofeedback in adolescents with ADHD: A randomized controlled trial. J. Clin. Psychiatry75, 535–542 (2014). [DOI] [PubMed] [Google Scholar]
- 28.Dobrakowski, P. & Łebecka, G. Individualized neurofeedback training may help achieve long-term improvement of working memory in children With ADHD. Clin. EEG. Neurosci.51, 94–101 (2020). [DOI] [PubMed] [Google Scholar]
- 29.Geladé, K. et al. An RCT into the effects of neurofeedback on neurocognitive functioning compared to stimulant medication and physical activity in children with ADHD. Eur. Child. Adolesc. Psychiatry26, 457–468 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Geladé, K. et al. A 6-month follow-up of an RCT on behavioral and neurocognitive effects of neurofeedback in children with ADHD. Eur. Child. Adoles. Psychiatry27, 581–593 (2018). [DOI] [PubMed] [Google Scholar]
- 31.Ging-Jehli, N. R., Kraemer, H. C., Eugene Arnold, L., Roley-Roberts, M. E. & de Beus, R. Cognitive markers for efficacy of neurofeedback for attention-deficit hyperactivity disorder - personalized medicine using computational psychiatry in a randomized clinical trial. J. Clin. Exp. Neuropsychol.45, 118–131 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Heinrich, H., Gevensleben, H., Freisleder, F. J., Moll, G. H. & Rothenberger, A. Training of slow cortical potentials in attention-deficit/hyperactivity disorder: Evidence for positive behavioral and neurophysiological effects. Biol. Psychiatry55, 772–775 (2004). [DOI] [PubMed] [Google Scholar]
- 33.Maurizio, S. et al. Comparing tomographic EEG neurofeedback and EMG biofeedback in children with attention-deficit/hyperactivity disorder. Biol. Psychol.95, 31–44 (2014). [DOI] [PubMed] [Google Scholar]
- 34.Moradi, N., Rajabi, S. & Mansouri Nejad, A. The effect of neurofeedback training combined with computer cognitive games on the time perception, attention, and working memory in children with ADHD. Appl. Neuropsychol. Chil.13, 24–36 (2024). [DOI] [PubMed] [Google Scholar]
- 35.Moreno-García, I., Meneres-Sancho, S., Camacho-Vara de Rey, C. & Servera, M. A randomized controlled trial to examine the posttreatment efficacy of neurofeedback, behavior therapy, and pharmacology on ADHD measures. J. Atten. Disord.23, 374–383 (2019). [DOI] [PubMed] [Google Scholar]
- 36.Shereena, E. A., Gupta, R. K., Bennett, C. N., Sagar, K. J. V. & Rajeswaran, J. EEG neurofeedback training in children with attention deficit/hyperactivity disorder: A cognitive and behavioral outcome study. Clin. EEG. Neurosci.50(4), 242–255 (2019). [DOI] [PubMed] [Google Scholar]
- 37.Steiner, N. J., Frenette, E. C., Rene, K. M., Brennan, R. T. & Perrin, E. C. Neurofeedback and cognitive attention training for children with attention-deficit hyperactivity disorder in schools. J. Dev. Behav. Pediatr.35, 18–27 (2014). [DOI] [PubMed] [Google Scholar]
- 38.Steiner, N. J., Sheldrick, R. C., Gotthelf, D. & Perrin, E. C. Computer-based attention training in the schools for children with attention deficit/hyperactivity disorder: A preliminary trial. Clin. Pediatr.50, 615–622 (2011). [DOI] [PubMed] [Google Scholar]
- 39.Vollebregt, M. A., van Dongen-Boomsma, M., Buitelaar, J. K. & Slaats-Willemse, D. Does EEG-neurofeedback improve neurocognitive functioning in children with attention-deficit/hyperactivity disorder? A systematic review and a double-blind placebo-controlled study. J. Child. Psychol. Psychiatry55, 460–472 (2014). [DOI] [PubMed] [Google Scholar]
- 40.Wangler, S. et al. Neurofeedback in children with ADHD: Specific event-related potential findings of a randomized controlled trial. Clin. Neurophysiol.122(5), 942–950 (2011). [DOI] [PubMed] [Google Scholar]
- 41.Lambez, B., Harwood-Gross, A., Golumbic, E. Z. & Rassovsky, Y. Non-pharmacological interventions for cognitive difficulties in ADHD: A systematic review and meta-analysis. J. Psychiatr. Res.120, 40–55 (2020). [DOI] [PubMed] [Google Scholar]
- 42.Viviani, G. & Vallesi, A. EEG-neurofeedback and executive function enhancement in healthy adults: A systematic review. Psychophysiology58(9), e13874 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Qiu, H., Liang, X., Wang, P., Zhang, H. & Shum, D. H. K. Efficacy of non-pharmacological interventions on executive functions in children and adolescents with ADHD: A systematic review and meta-analysis. Asian. J. Psychiatr.87, 103692 (2023). [DOI] [PubMed] [Google Scholar]
- 44.Louthrenoo, O., Boonchooduang, N., Likhitweerawong, N., Charoenkwan, K. & Srisurapanont, M. The effects of neurofeedback on executive functioning in children with ADHD: A meta-analysis. J. Atten. Disord.26, 976–984 (2022). [DOI] [PubMed] [Google Scholar]
- 45.Wong, K. P., Qin, J., Xie, Y. J. & Zhang, B. Effectiveness of technology-based interventions for school-age children with attention-deficit/hyperactivity disorder: Systematic review and meta-analysis of randomized controlled trials. JMIR. Ment. Health.10, e51459 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Zuberer, A., Minder, F., Brandeis, D. & Drechsler, R. Mixed-effects modeling of neurofeedback self-regulation performance: Moderators for learning in children with ADHD. Neural. Plast.2018, 2464310 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Van Doren, J. et al. Sustained effects of neurofeedback in ADHD: A systematic review and meta-analysis. Eur. Child. Adolesc. Psychiatry28, 293–305 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Riccio, C. A. & Gomes, H. Interventions for executive function deficits in children and adolescents. Appl. Neuropsych. Chil.2, 133–140 (2013). [DOI] [PubMed] [Google Scholar]
- 49.Neuhäußer, A. M., Bluschke, A., Roessner, V. & Beste, C. Distinct effects of different neurofeedback protocols on the neural mechanisms of response inhibition in ADHD. Clin. Neurophysiol.153, 111–122 (2023). [DOI] [PubMed] [Google Scholar]
- 50.Bluschke, A. et al. The effects of different theta and beta neurofeedback training protocols on cognitive control in ADHD. J. Cogn. Enhance.6(4), 463–477 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Pahlevanian, A. et al. Neurofeedback associated with neurocognitive-rehabilitation training on children with attention-deficit/hyperactivity disorder (ADHD). Int. J. Ment. Health. Addict.15, 1–10 (2015). [Google Scholar]
- 52.Zhang, D. W., Johnstone, S., Li, H., Luo, X. & Sun, L. Comparing the transfer effects of three neurocognitive training protocols in children with attention-deficit/hyperactivity disorder: A single-case experimental design. Behav. Change40, 11–29 (2021). [Google Scholar]
- 53.Johnstone, S. J., Roodenrys, S. J., Johnson, K., Bonfield, R. & Bennett, S. J. Game-based combined cognitive and neurofeedback training using Focus Pocus reduces symptom severity in children with diagnosed AD/HD and subclinical AD/HD. Int. J. Psychophysiol.116, 32–44 (2017). [DOI] [PubMed] [Google Scholar]
- 54.Rajabi, S., Pakize, A. & Moradi, N. Effect of combined neurofeedback and game-based cognitive training on the treatment of ADHD: A randomized controlled study. Appl. Neuropsych. Chil.9, 193–205 (2020). [DOI] [PubMed] [Google Scholar]
- 55.Luo, X. et al. A randomized controlled study of remote computerized cognitive, neurofeedback, and combined training in the treatment of children with attention-deficit/hyperactivity disorder. Eur. Child. Adolesc. Psychiatry32, 1475–1486 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Roy, S. et al. Effectiveness of neurofeedback training, behaviour management including attention enhancement training and medication in children with attention-deficit/hyperactivity disorder—A comparative follow up study. Asian. J. Psychiatr.76, 103133 (2022). [DOI] [PubMed] [Google Scholar]
- 57.Li, L., Yang, L., Zhuo, C. J. & Wang, Y. F. A randomised controlled trial of combined EEG feedback and methylphenidate therapy for the treatment of ADHD. Swiss. Med. Wkly.143, w13838 (2013). [DOI] [PubMed] [Google Scholar]
- 58.Lee, E. J. & Jung, C. H. Additive effects of neurofeedback on the treatment of ADHD: A randomized controlled study. Asian. J. Psychiatry25, 16–21 (2017). [DOI] [PubMed] [Google Scholar]
- 59.Geladé, K. et al. Behavioral effects of neurofeedback compared to stimulants and physical activity in attention-deficit/hyperactivity disorder: A randomized controlled trial. J. Clin. Psychiatry77, e1270–e1277 (2016). [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.








